Header image  
University of Connecticut
Health Center
 
line decor
  HOME  ::  
line decor
 
 
 
Ivo Kalajzik, M.D.

Kalajzik Lab

 
PUBLICATIONS

Kalajzic, I., Staal, A., Yang, W., Wu, Y., Johnson, S.E., Feyen, J.H.M., Krueger, W., Maye, P., Yu, F., Zhao, Y., Kuo, L., Gupta, R.R., Achenie, L.E.K., Wang,H., Shin, D. and Rowe, D.W. 2005. Expression profile of osteoblast lineage at defined stages of differentiation. J Biol Chem (April 15 published online ahead of print). 

Yang W, Lu Y, Kalajzic I, Guo D, Harris MA, Gluhak-Heinrich J, Kotha S, Bonewald LF, Feng JQ, Rowe DW, Turner CH, Robling AG, Harris SE. 2005. Dentin matrix protein 1 gene cis-regulation: Use In osteocytes to characterize local responses to mechanical loading in vitro and In vivo. J Biol Chem (Feb 22 published online ahead of print).

Lukic, I.K., Grcevic, D., Kovacic, N., Katavic, V., Ivcevic, S., Kalajzic, I., Marusic, A. 2005. TNF-a receptor 1 Controls Endochondral Bone Formation in Adult Mice. Clinical and Experimental Immunology 139:236-244.

Yang, W., Kalajzic, I., Lu, Y., Guo, D., Harris, M.A., Gluhak-Heinrich, J., Bonewald, L.F., Feng, J.Q., Rowe, D.W., Harris, S.E. 2004. In vitro and In vivo study on osteocyte-specific mechanical signaling pathways. J Musculoskelet Neuron Interact. 4:386-387.

Katavic, V., Grcevic, D., Lukic, IK., Vucenik, V., Kovacic, N., Kalajzic, I. and Marusic, A. 2003. Non-functional Fas ligand increases the formation of cartilage early in the endochondral bone induction bby rhBMP-2. Life Sciences 74:13-28.

Kalajzic, I., Braut, A., Guo, D., Jiang, X., Kronenberg, M.S., Mina, M., Harris, S.E., Harris, S.E. and D.W. Rowe. Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene. Bone 35:74-82.

Delany, A.M., Kalajzic, I. , Bradshaw, A.D., Sage, E.H. and Canalis, E. 2003. Osteonectin-null mutation compromises osteoblasts formation, maturation and survival. Endocrinology, 144(6):2588-2596

Rajan, T.V., Paciorkowski, N., Kalajzic, I. and McGuiness, I. 2003. Ascorbic acid is a requirement for the morphogenesis of the human filarial parasite Brugia malayi. J Parasit., 89 (4):868-870.

Kalajzic, I. , Kalajzic Z., Hurley, M.M., Lichtler A.C. and Rowe D.W. 2003. Stage specific inhibition of osteoblast lineage differentiation by FGF2 and noggin. J. Cell Biochem., 88: 1168-1176.

Kalajzic, Z., Liu, P., Kalajzic, I. , Du, Z., Braut, A., Mina, M., Canalis, E. and Rowe, D.W. 2002. Directing the expression of a GFP transgene in differentiated osteoblasts: Comparison between collagen and osteocalcin promoters. Bone, 31: 654-660.

Kalajzic, I. , Terzic, J., Rumboldt, Z., Mack, K., Naprta, A., Ledgard, F., Gronowicz, G., Clark, S.H. and Rowe, D.W. 2002. Osteoblastic Response to the Defective Matrix in the Osteogenesis Imperfecta Murine (OIM) Mouse. Endocrinology, 143: 1594-1601.

Braut, A., Kalajzic, I. , Kalajzic, Z., Rowe, D.W., Kollar, E.J. and Mina M. 2002. Col1a1-GFP transgene expression in developing incisors. Connect Tissue Res., 43: 216-9.

Kalajzic, I. , Kalajzic, Z., Kaliterna, M., Gronowicz, G., Clark, S.H., Lichtler, A.C. and Rowe, D.W. 2002. Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage. J. Bone Miner. Res., 17: 15-25.

Primorac D., Rowe D.W., Mottes M., Barisic I., Anticevic D., Mirandola S., Gomez LIra M., Kalajzic, I. , Kusec V. and Glorieux FH. 2001. Osteogenesis Imperfecta at the beginning of bone and joint decade. Croat. Med. J., 42: 392-414.

Visnjic, D., Kalajzic, I. , Gronowicz, G., Clark, S.H., Lichtler, A.C. and Rowe, D.W. 2001. Conditional ablation of the osteoblast lineage in Col2.3deltatk transgenic mice. J. Bone Miner. Res., 16: 2222-2232.

Liu, P. Kalajzic, I. , Stover ML., Rowe D.W, Lichtler A.C. 2001. Human bone marrow stromal cells are efficiently transduced by VSV pseudotyped retrovectors without affecting subsequent osteoblastic differentiation. Bone, 29: 331-335.

Dacic S., Kalajzic, I. , Visnjic D., Lichtler A.C., Rowe D.W. 2001. Col1a1-driven transgenic markers of osteoblast lineage progression. J. Bone Miner. Res., 16: 1228-1236.

Kalajzic, I. , Stover ML., Liu P., Kalajzic Z., Rowe D.W. and Lichtler A.C. 2001. Use of VSV-G pseudotyped retroviral vectors to target murine osteoprogenitor cells. Virology, 284: 37-45.

Stover ML., Wang CH.L., McKinstry M., Kalajzic, I. , Gronowicz G., Clark S.H., Rowe D.W. and Lichtler A.C. 2001. Bone directed expression of Col1a1 promoter driven self-inactivating retroviral vector in bone marrow cells and in transgenic mice. Mol. Ther., 3: 543-550.

Marusic A., Grcevic D., Katavic V., Kovacic N., Lukic I.K., Kalajzic, I. , Lorenzo J.A. 2000. Role of B-lymphocytes in new bone formation. Lab. Invest., 80: 1761-1774.

 
LAB MEMBERS
Ivo Kalajzik, M.D., Principal Investigator

ROTATIONS

Coming soon.